Navigation Links
SU research team uses nanobiotechnology-manipulated light particles to accelerate algae growth
Date:8/24/2010

Scientists and engineers seek to meet three goals in the production of biofuels from non-edible sources such as microalgae: efficiency, economical production and ecological sustainability. Syracuse University's Radhakrishna Sureshkumar, professor and chair of biomedical and chemical engineering in the L.C. Smith College of Engineering and Computer Science, and SU chemical engineering Ph.D. student Satvik Wani have uncovered a process that is a promising step toward accomplishing these three goals.

Sureshkumar and Wani have discovered a method to make algae, which can be used in the production of biofuels, grow faster by manipulating light particles through the use of nanobiotechnology. By creating accelerated photosynthesis, algae will grow faster with minimal change in the ecological resources required. This method is highlighted in the August 2010 issue of Nature Magazine.

The SU team has developed a new bioreactor that can enhance algae growth. They accomplished this by utilizing nanoparticles that selectively scatter blue light, promoting algae metabolism. When the optimal combination of light and confined nanoparticle suspension configuration was used, the team was able to achieve growth enhancement of an algae sample of greater than 30 percent as compared to a control.

"Algae produce triglycerides, which consist of fatty acids and glycerin. The fatty acids can be turned into biodiesel while the glycerin is a valuable byproduct," says Sureshkumar. "Molecular biologists are actively seeking ways to engineer optimal algae strains for biofuel production. Enhancing the phototropic growth rate of such optimal organisms translates to increased productivity in harvesting the feedstock."

The process involved the creation of a miniature bioreactor that consisted of a petri dish of a strain of green algae (Chlamydomonas reinhardtii) on top of another dish containing a suspension of silver nanoparticles that served to backscatter blue light into the algae culture. Through model-guided experimentation, the team discovered that by varying the concentration and size of the nanoparticle solution they could manipulate the intensity and frequency of the light source, thereby achieving an optimal wavelength for algal growth.

"Implementation of easily tunable wavelength specific backscattering on larger scales still remains a challenge, but its realization will have a substantial impact on the efficient harvesting of phototrophic microorganisms and reducing parasitic growth," says Sureshkumar. "Devices that can convert light not utilized by the algae into the useful blue spectral regime can also be envisioned."

To date, this is one of the first explorations into utilizing nanobiotechnology to promote microalgal growth. The acceleration in the growth rate of algae also had numerous benefits outside the area of biofuel production. Sureshkumar and Wani will be looking to employ this discovery to further their research in creating environmental sensors for ecological warning systems.


'/>"/>

Contact: Ariel DuChene
adduchen@syr.edu
315-443-2546
Syracuse University
Source:Eurekalert

Related biology technology :

1. BioFortis and Catholic Health Initiatives Center for Translational Research Announce Biorepository Information Technology Strategic Partnership to Drive Progress in Personalized Medicine
2. Castor Bean Genome Published by Research Team Including Scientists from the Venter Institute
3. US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
4. Researchers stretch a lackluster material into a possible electronics revolution
5. ASU industry research consortium poised to expand
6. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
7. K-State Research Team Investigates Mutated Genes Role in Breast Cancer
8. Researchers successfully test new alternative to traditional semiconductors
9. WSU researchers use super-high pressures to create super battery
10. Pitt-led researchers to build foundation for quantum supercomputers with $7.5 million federal grant
11. Octapharma Grants Program Awards First Research Grant to Rush University Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... ) today announced the submission of a Marketing Authorization Application ... a biosimilar candidate to Avastin ® (bevacizumab). The companies ... to the EMA. "The submission of ABP ... seeks to expand our oncology portfolio," said Sean E. ...
(Date:12/2/2016)... ... , ... ACEA Biosciences, Inc. announced today that it will be presenting updated ... World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
Breaking Biology Technology:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):